Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux

Otolaryngology - Head and Neck Surgery

Volumn 139, Issue 3, 2008, Pages 414-420

  Reichel, Oliver ^a   Dressel, Holger ^b   Wiederänders, Katrin ^a   Issing, Wolfgang J ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERTROPHY; LARYNGOPHARYNGEAL REFLUX; MAJOR CLINICAL STUDY; MALE; PHYSICAL DISEASE BY BODY FUNCTION; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; HYPERTROPHY; HYPOPHARYNX; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS;

EID: 49549092264     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2008.06.003     Document Type: Article

References (20)

1. Altman K.W., Stephens R.M., Lyttle C.S., et al. Changing impact of gastroesophageal reflux in medical and otolaryngology practice. Laryngoscope 115 (2005) 1145-1153
2. Koufman J.A., Aviv J.E., Casiano R.R., et al. Laryngopharyngeal reflux: position statement of the Committee on Speech, Voice, and Swallowing Disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 127 (2002) 32-35
3. Ford C.N. Evaluation and management of laryngopharyngeal reflux. JAMA 294 (2005) 1534-1540
4. Reichel O., Keller J., Rasp G., et al. Efficacy of once-daily esomeprazole treatment in patients with laryngopharyngeal reflux evaluated by 24-hour pH monitoring. Otolaryngol Head Neck Surg 136 (2007) 205-210
5. Karkos P.D., and Wilson J.A. Empiric treatment of laryngopharyngeal reflux with proton pump inhibitors: a systemativ review. Laryngoscope 116 (2006) 144-148
6. Havas T., Huang S., Levy M., et al. Posterior pharyngolaryngitis: double-blind, randomised placebo-controlled trial of proton pump inhibitor therapy. Aust J Otolaryngol 3 (1999) 243-246
7. Steward D.L., Wilson K.M., Kelly D.H., et al. Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngol Head Neck Surg 131 (2004) 342-350
8. Wo J.M., Koopman J., Harrell S.P., et al. Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux. Am J Gastroenterol 101 (2006) 1972-1978
9. Vaezi M.F., Richter J.E., Stasney C.R., et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 116 (2006) 254-260
10. Miner Jr. P., Katz P.O., Chen Y., et al. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. Am J Gastroenterol 98 (2003) 2616-2620
11. Belafsky P.C., Postma G.N., and Koufman J.A. The validity and reliability of the reflux finding score (RFS). Laryngoscope 111 (2001) 1313-1317
12. Belafsky P.C., Postma G.N., and Koufman J.A. Validity and reliability of the Reflux Symptom Index (RSI). J Voice 16 (2002) 274-277
13. Noordzij J.P., Khidr A., Evans B.A., et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 111 (2001) 2147-2151
14. Koufman J.A. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 101 suppl 53 (1991) 1-78
15. Kamel P.L., Hanson D., and Kahrilas P.J. Omeprazole for the treatment of posterior laryngitis. Am J Med 96 (1994) 321-326
16. Eherer A.J., Habermann W., Hammer H.F., et al. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. Scand J Gastroenterol 38 (2003) 462-467
17. Belafsky P.C., Postma G.N., and Koufman J.A. Laryngopharyngeal reflux symptoms improve before changes in physical findings. Laryngoscope 111 (2001) 979-981
18. El-Serag H.B., Lee P., Buchner A., et al. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 96 (2001) 979-983
19. Book D.T., Rhee J.S., Toohill R.J., et al. Perspectives in laryngopharyngeal reflux: an international survey. Laryngoscope 112 (2002) 1399-1406
20. DelGaudio J.M., and Waring J.P. Empiric esomeprazole in the treatment of laryngopharyngeal reflux. Laryngoscope 113 (2003) 598-601